COMPANION DIAGNOSTIC MARKETS

$3,500.00

SEE the Table of Contents.

GET the Free Sample of this Report.

Many organizations subscribe to all or some of our reports.  You may already have free access to this report. FIND out Here.

" COMPANION DIAGNOSTIC MARKETS, THE FUTURE OF DIAGNOSTICS BY APPLICATION, TECHNOLOGY AND FUNDING.  WITH EXECUTIVE AND CONSULTANT GUIDES 2025-2029"

Companion Diagnostics are changing cancer management and changing how drugs are developed. Artificial Intelligence comes into play….”

 529 pages packed with information.

Companion Diagnostics are changing the diagnostics industry.  Whole new markets are emerging.   Diagnostic and Therapeutic partnerships.  Find out the latest outlook for this important market and the Impact of Artificial Intelligence.

Will Companion Diagnostics become the norm?

Learn all about how diagnostic players are jockeying for position with their pharmaceutical counterparts and creating new and significant business opportunities.  And some players are already taking the lead.  It is a dynamic market situation with enormous opportunity.  Diagnostic companies are trying to back the right horse.  The science is racing forward.  And the cost picture is changing.

"Companion Diagnostic Markets, the Future of Diagnostics” provides data that analysts and planners can use. Hundreds of pages of information.   Get specific growth and market sizes for your area of interest.  Assistance in using the information is normally provided without additional charges. 

The report includes detailed breakouts for 18 Countries and 4 Regions.  A detailed breakout for any country or specific area in the world is available to purchasers of the report.

 

SEE the Table of Contents.

GET the Free Sample of this Report.

Many organizations subscribe to all or some of our reports.  You may already have free access to this report. FIND out Here.

ABOUT THE LEAD AUTHOR


Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research.  His education includes:

Finance for Senior Executives - Harvard Business School

Market Research  - Burke Institute

M.B.A. (Finance and Policy) - University of British Columbia

B.Sc. (Chemistry) - University of British Columbia

He is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.

Related products